Drug Profile
Metoclopramide high-dose
Alternative Names: SensamideLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator OXiGENE
- Class Aminobenzoic acids; Antiemetics; Antineoplastics; Benzamides; Chlorobenzenes; Diethylamines; Gastrokinetics; Phenyl ethers; Radiation-sensitising agents; Radiosensitisers; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Non-small cell lung cancer; Squamous cell cancer
Most Recent Events
- 11 Jun 2002 Discontinued - Phase-III for Non-small cell lung cancer in European Union (unspecified route)
- 11 Jun 2002 Discontinued - Phase-III for Squamous cell cancer in European Union (unspecified route)
- 11 Jun 2002 Discontinued - Phase-III for Squamous cell cancer in USA (unspecified route)